The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications

<i>Helicobacter pylori</i> (<i>H. pylori</i>) is a notorious, recalcitrant and silent germ, which can cause a variety of debilitating stomach diseases, including gastric and duodenal ulcers and gastric cancer. This microbe predominantly colonizes the mucosal layer of the human stomach and survives in the inhospitable gastric microenvironment, by adapting to this hostile milieu. In this review, we first discuss <i>H. pylori</i> colonization and invasion. Thereafter, we provide a survey of current curative options based on polypharmacy, looking at pharmacokinetics, pharmacodynamics and pharmaceutical microbiology concepts, in the battle against <i>H. pylori</i> infection.